Letter to the editor in response to “Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Letter to the editor in response to “Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy”

Published:2024-07 Issue:Suppl 4 Volume:72 Page:S716-S717
ISSN:0301-4738
Container-title:Indian Journal of Ophthalmology
language:en
Short-container-title:

Author:

Verghese Shishir¹,Ranjan Ratnesh²,Manayath George J³

Affiliation:

1. Consultant Vitreoretinal Surgeon, Vitreoretinal Services, Amita Eye Care, Tiruvalla, Kerala, India

2. Consultant Vitreoretinal Surgeon, Vitreoretinal Services, Drishtipunj Eye Hospital, Danapur, Bihar, India

3. Senior Medical Officer, Vitreoretinal Services, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Coimbatore, Tamil Nadu, India

Publisher

Medknow

Reference5 articles.

1. Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy;Sandeep;Indian J Ophthalmol,2023

2. Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies;Zhang;Eye Vis,2023

3. Intravitreal bevacizumab and ranibizumab in the treatment of acute central serous chorioretihopathy: A single center retrospective study;Tekin;Semin Ophthalmol,2018

4. Intravitreal bevacizumab for treatment of central serous chorioretinopathy;Ünlü;J Ophthalmic Vis Res,2016

5. Central serous chorioretinopathy: Pathogenesis and management;Semeraro;Clin Ophthalmol,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP